4.7 Article

USP28 facilitates pancreatic cancer progression through activation of Wnt/beta-catenin pathway via stabilising FOXM1

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

USP37 promotes deubiquitination of HIF2 α in cancer

Kai Hong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Biotechnology & Applied Microbiology

Ubiquitin-specific peptidase 28 enhances STAT3 signaling and promotes cell growth in non-small-cell lung cancer

Pengling Li et al.

ONCOTARGETS AND THERAPY (2019)

Article Oncology

FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression

Guohui Hu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Oncology

The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin

Samriddhi Shukla et al.

MOLECULAR CANCER THERAPEUTICS (2019)

Review Oncology

DUBs, Hypoxia, and Cancer

Daniela Mennerich et al.

TRENDS IN CANCER (2019)

Review Cell Biology

Targeting deubiquitinase USP28 for cancer therapy

Xiaofang Wang et al.

CELL DEATH & DISEASE (2018)

Review Gastroenterology & Hepatology

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

Andrew McGuigan et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Article Biochemistry & Molecular Biology

OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance

U. Karunarathna et al.

ONCOGENE (2016)

Article Biochemistry & Molecular Biology

Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation

Yaohui Chen et al.

EMBO JOURNAL (2016)

Article

FoxM1 as a Novel Therapeutic Target for Cancer Drug Therapy

Xin-Sen Xu et al.

Asian Pacific Journal of Cancer Prevention (2015)

Article Oncology

Usp28 Counteracts Fbw7 in Intestinal Homeostasis and Cancer

Markus E. Diefenbacher et al.

CANCER RESEARCH (2015)

Article Biochemistry & Molecular Biology

SUMOylation inhibits FOXM1 activity and delays mitotic transition

S. S. Myatt et al.

ONCOGENE (2014)

Review Pharmacology & Pharmacy

Targeting FOXM1 in cancer

Marianna Halasi et al.

BIOCHEMICAL PHARMACOLOGY (2013)

Review Pharmacology & Pharmacy

Role of Wnt/β-catenin Signaling in Drug Resistance of Pancreatic Cancer

Jiujie Cui et al.

CURRENT PHARMACEUTICAL DESIGN (2012)

Review Gastroenterology & Hepatology

Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers

Bryan D. White et al.

GASTROENTEROLOGY (2012)

Review Medicine, General & Internal

Pancreatic Cancer

Manuel Hidalgo

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Cell Biology

Breaking the chains: structure and function of the deubiquitinases

David Komander et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)

Review Biochemistry & Molecular Biology

The Database dbEST Correctly Predicts Gene Expression in Colon Cancer Patients

M. Radeva et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)

Article Biochemistry & Molecular Biology

An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle

H. J. Park et al.

ONCOGENE (2008)

Article Cell Biology

The ubiquitin-specific protease USP28 is required for MYC stability

Nikita Popov et al.

NATURE CELL BIOLOGY (2007)